Benjamin Harshbarger insider trades

Open-market stock purchases and sales by Benjamin Harshbarger, Chief Legal Officer at Astria Therapeutics, Inc, from SEC Form 4 filings since Sep 17, 2015.

Recent trades

DateStockTradeValue
Jan 23, 2026ATXS Astria Therapeutics, IncSold (not open market)$432K
Jan 23, 2026ATXS Astria Therapeutics, IncSold (not open market)$358K
Jan 23, 2026ATXS Astria Therapeutics, IncSold (not open market)$1.7M

Companies traded

  • ATXS Astria Therapeutics, Inc: other filings, last Jan 23, 2026
  • CATB Catabasis Pharmaceuticals Inc: other filings, last Jun 8, 2021
  • NVLN Novelion Therapeutics Inc: other filings, last May 9, 2019
  • AEGR Aegerion Pharmaceuticals, Inc: other filings, last Nov 29, 2016

Get free alerts when Benjamin Harshbarger files a new trade →